Are glucocorticoid-induced osteoporosis recommendations suffi cient to determine antiosteoporotic treatment for patients with rheumatoid arthritis?
Joo-Hyun Lee, Soo-Kyung Cho, Minkyung Han, Dam Kim, Sang-Cheol Bae, Yoon-Kyoung Sung
Korean J Intern Med. 2014;29(4):509-515. Published online 2014 Jun 27 DOI: https://doi.org/10.3904/kjim.2014.29.4.509
Citations to this article as recorded by 
Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis
Y. Wang, R. Zhao, Z. Gu, C. Dong, G. Guo, L. Li
Osteoporosis International.2020; 31(8): 1401. CrossRef
Intervention Thresholds for Treatment in Patients with Glucocorticoid-Induced Osteoporosis: Systematic Review of Guidelines
Tae-Han Lee, Yeo-Jin Song, Hyoungyoung Kim, Yoon-Kyoung Sung, Soo-Kyung Cho
Journal of Bone Metabolism.2020; 27(4): 247. CrossRef
Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
Ji-Heh Park, Eun-Kyoung Park, Dong-Wan Koo, Shinwon Lee, Sun-Hee Lee, Geun-Tae Kim, Seung-Geun Lee
BMC Musculoskeletal Disorders.2017;[Epub] CrossRef
Risk Factors of Osteoporosis in Rheumatoid Arthritis Patients; Glucocorticoid, Inactivity, or Nutrient Deficiencies
Yoon-Kyoung Sung
Journal of Rheumatic Diseases.2017; 24(2): 63. CrossRef
Proper time to initiate antiosteoporotic treatment in rheumatoid arthritis with or without glucocorticoid use
Sang-Won Lee
The Korean Journal of Internal Medicine.2014; 29(4): 434. CrossRef